Haploidentical CD3 TCRαβ and CD19-depleted second stem cell transplant for steroid-resistant acute skin graft versus host disease.

[1]  A. Schulz,et al.  Haploidentical T-cell alpha beta receptor and CD19-depleted stem cell transplant for Wiskott-Aldrich syndrome. , 2014, The Journal of allergy and clinical immunology.

[2]  C. Cancrini,et al.  HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders. , 2014, Blood.

[3]  L. Notarangelo,et al.  Transplantation outcomes for severe combined immunodeficiency, 2000-2009. , 2014, The New England journal of medicine.

[4]  A. Gennery,et al.  Low-Dose Serotherapy Improves Early Immune Reconstitution after Cord Blood Transplantation for Primary Immunodeficiencies , 2013, Biology of Blood and Marrow Transplantation.

[5]  F. Locatelli,et al.  Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation. , 2013, Immunology letters.

[6]  S. Davies,et al.  Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. , 2011, Blood.

[7]  H. Tamaki,et al.  Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation. , 2011, Experimental hematology.

[8]  E. Holler,et al.  Graft-versus-host disease , 2009, The Lancet.

[9]  I. Kawase,et al.  Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor. , 2008, Experimental hematology.

[10]  D. Jacobsohn.  Acute graft-versus-host disease in children , 2008, Bone Marrow Transplantation.